SecBot SecBot
144 ·Filed Nov 2, 2026

TNGX

Tango Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 7h ago SEC0001950047-26-010577
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is pre-planned under a 10b5-1 arrangement and follows a pattern of monthly sales by the officer. No new directional signal; monitor for any change in the pattern or a filing of a new 10b5-1 plan.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$23.17
T+0 close · Nov 2, 2026 · via day close
Latest settled
+4.88%
T+5 · $24.30 · next T+20 in 15d
Vs SPY
+5.46%
α at T+5
Latest observation
+11.60%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $23.17entry
  2. T+1 · 13d ago +0.04%α −1.61% · $23.18
  3. T+5 · 7d ago +4.88%α +5.46% · $24.30
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Adam Crystal, an officer of Tango Therapeutics, filed a Form 144 notice of intent to sell 20,000 shares of common stock, valued at approximately $454,400, on November 2, 2026. The shares are to be acquired through the exercise of stock options, and the sale is part of a pre-existing 10b5-1 trading plan, with prior monthly sales of 27,000 shares each in August, September, and October 2026. This is a routine insider sale under a plan, not a discretionary signal.

Key Facts

  • Insider Adam Crystal (Officer) filed Form 144 to sell 20,000 shares of Tango Therapeutics common stock.
  • Estimated sale value: $454,400 (based on $22.72 per share, derived from the filing's total value and share count).
  • Shares to be sold are acquired via exercise of stock options.
  • Sale is part of a 10b5-1 trading plan; prior sales under the same plan: 27,000 shares on 10/01/2026 ($660,797), 09/01/2026 ($603,910), and 08/03/2026 ($735,518).
  • Proposed sale date: November 2, 2026.
  • Market cap of TNGX is $3.8B; the sale represents about 0.012% of market cap.

Financial Impact

Proposed sale of 20,000 shares valued at $454,400, representing a small fraction of market cap (0.012%) and consistent with prior monthly sales under a 10b5-1 plan.

dilutioninsider holdings

Risk Factors

  • Insider selling under a 10b5-1 plan is routine, but continued large monthly sales could indicate a desire to reduce exposure.
  • No material risk identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010577
Document: 0001950047-26-010577-index.html0001950047-26-010577
Document: 0001950047-26-010577.txt0001950047-26-010577

Track record

27 reports on TNGX

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
  3. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
  4. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
  6. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $23.17 Now $24.17 +4.32% settles Feb 1
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
  9. Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
  10. Aug 11, 202613w ago 8-K Bullish 7/10 No price data
Showing 10 of 27

US Market Status

Market Closed · Opens in 9h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026